This is a Validated Antibody Database (VAD) review about human TWIST1, based on 71 published articles (read how Labome selects the articles), using TWIST1 antibody in all methods. It is aimed to help Labome visitors find the most suited TWIST1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TWIST1 synonym: ACS3; BPES2; BPES3; CRS; CRS1; CSO; SCS; SWCOS; TWIST; bHLHa38

Abcam
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:100; fig 3e
Abcam TWIST1 antibody (abcam, ab50887) was used in western blot on human samples at 1:100 (fig 3e). Am J Cancer Res (2022) ncbi
domestic rabbit monoclonal (EP18178)
  • western blot; rat; 1:500; loading ...; fig 5b
Abcam TWIST1 antibody (Abcam, ab187008) was used in western blot on rat samples at 1:500 (fig 5b). Cell Death Discov (2022) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 5c
Abcam TWIST1 antibody (Abcam, ab50581) was used in western blot on rat samples at 1:1000 (fig 5c). Cell Death Discov (2022) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; mouse; loading ...; fig 1e
  • western blot; mouse; loading ...; fig 1c
  • immunohistochemistry; human; loading ...; fig 1a
Abcam TWIST1 antibody (Abcam, 50887) was used in immunohistochemistry on mouse samples (fig 1e), in western blot on mouse samples (fig 1c) and in immunohistochemistry on human samples (fig 1a). JCI Insight (2021) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; mouse; 1:200; loading ...; fig s10a
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on mouse samples at 1:200 (fig s10a). NPJ Breast Cancer (2021) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; mouse; loading ...; fig 3g
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry on mouse samples (fig 3g). Nat Commun (2021) ncbi
mouse monoclonal (10E4E6)
  • immunocytochemistry; human; 1:100; loading ...; fig 5s1a
  • western blot; human; 1:100; loading ...; fig 5s1a
Abcam TWIST1 antibody (abcam, ab175430) was used in immunocytochemistry on human samples at 1:100 (fig 5s1a) and in western blot on human samples at 1:100 (fig 5s1a). elife (2020) ncbi
domestic rabbit monoclonal (EP18178)
  • western blot; human; loading ...; fig s1d
Abcam TWIST1 antibody (Abcam, ab187008) was used in western blot on human samples (fig s1d). BMC Cancer (2019) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:50; loading ...; fig 4c, 4h, 5b
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples at 1:50 (fig 4c, 4h, 5b). Stem Cells (2019) ncbi
mouse monoclonal (10E4E6)
  • western blot; human; 1:2000; loading ...; fig 5d
Abcam TWIST1 antibody (Abcam, ab175430) was used in western blot on human samples at 1:2000 (fig 5d). Exp Cell Res (2018) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; mouse; loading ...; fig 10a
Abcam TWIST1 antibody (abcam, ab50887) was used in immunohistochemistry on mouse samples (fig 10a). Dev Biol (2017) ncbi
mouse monoclonal (10E4E6)
  • western blot; human; 1:500; loading ...; fig 6B; 6D; 6F
Abcam TWIST1 antibody (Abcam, ab175430) was used in western blot on human samples at 1:500 (fig 6B; 6D; 6F). Onco Targets Ther (2017) ncbi
mouse monoclonal (Twist2C1a)
  • immunocytochemistry; human; fig S7c
  • western blot; human; fig 2a
  • western blot; dogs; fig 6f
  • western blot; mouse; fig 7i
In order to report that TrkC contributes to tumorigenicity, metastasis, and self-renewal traits of metastatic breast cancer, Abcam TWIST1 antibody (Abcam, ab50887) was used in immunocytochemistry on human samples (fig S7c), in western blot on human samples (fig 2a), in western blot on dogs samples (fig 6f) and in western blot on mouse samples (fig 7i). Sci Rep (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 1b
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (10E4E6)
  • western blot; human; fig 3
Abcam TWIST1 antibody (abcam, ab175430) was used in western blot on human samples (fig 3). Cancer Gene Ther (2016) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human; fig 2
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 3b
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • chromatin immunoprecipitation; human; fig s4
Abcam TWIST1 antibody (Abcam, Ab50887) was used in chromatin immunoprecipitation on human samples (fig s4). Nat Commun (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; fig 7
Abcam TWIST1 antibody (abcam, ab50887) was used in western blot on human samples (fig 7). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 4e
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples (fig 4e). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to classify familial breast cancer patients and their immunoprofile from tissue microarrays, Abcam TWIST1 antibody (Abcam, Twist2C1a) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; human; fig 6
In order to elucidate how miR-373 decreases TXNIP and promotes metastasis, Abcam TWIST1 antibody (Abcam, Ab50887) was used in immunohistochemistry on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). BMC Cancer (2015) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; fig 5
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples (fig 5). Int J Mol Med (2015) ncbi
mouse monoclonal (Twist2C1a)
  • chromatin immunoprecipitation; human; loading ...; fig 3
  • western blot; human; loading ...; fig 2b
Abcam TWIST1 antibody (Abcam, ab50887) was used in chromatin immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 2b). J Immunol (2015) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human
Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; human; 1:50
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Abcam TWIST1 antibody (Abcam, Ab50887) was used in immunohistochemistry on human samples at 1:50. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; human; 1:100
  • western blot; human; 1:1000
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry on human samples at 1:100 and in western blot on human samples at 1:1000. World J Gastroenterol (2014) ncbi
mouse monoclonal (Twist2C1a)
  • chromatin immunoprecipitation; human; 1 ug/ml
  • immunohistochemistry; human; 1:100
  • western blot; human; 1:1000
Abcam TWIST1 antibody (Abcam, ab50887) was used in chromatin immunoprecipitation on human samples at 1 ug/ml, in immunohistochemistry on human samples at 1:100 and in western blot on human samples at 1:1000. Cancer Res (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunoprecipitation; human; 1:70; fig 7
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Abcam TWIST1 antibody (Abcam, ab50887) was used in immunoprecipitation on human samples at 1:70 (fig 7). Nat Cell Biol (2014) ncbi
mouse monoclonal (10E4E6)
  • western blot; human
Abcam TWIST1 antibody (Abcam, ab175430) was used in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:50; fig 1a
In order to show that the zinc finger E-box binding homeobox 1 regulates radiosensitivity and the DNA damage response in breast cancer cells, Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples at 1:50 (fig 1a). Nat Cell Biol (2014) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; mouse; 1:50
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on human samples . Int J Biol Sci (2014) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; human; 1:250
In order to discuss a clinical case of intracranial extension of adenoid cystic carcinoma, Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry on human samples at 1:250. BMC Res Notes (2014) ncbi
mouse monoclonal (Twist2C1a)
  • immunocytochemistry; human
  • western blot; human
In order to evaluate the prognostic value of fascin in pancreatic cancer, Abcam TWIST1 antibody (Abcam, ab50887) was used in immunocytochemistry on human samples and in western blot on human samples . Gastroenterology (2014) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human
In order to study the role of TWIST1 in the mechanism by which KLF17 induces epithelial-to-mesenchymal transition in endometrioid endometrial cancer, Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples . Carcinogenesis (2014) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; mouse
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on mouse samples . Am J Pathol (2013) ncbi
mouse monoclonal (Twist2C1a)
  • immunocytochemistry; mouse; 1:200
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunocytochemistry on mouse samples at 1:200. Mol Endocrinol (2013) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; mouse; 1:200
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Development (2013) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry; human; 1:250
In order to characterize a rare case of gliosarcoma, Abcam TWIST1 antibody (abcam, ab50887) was used in immunohistochemistry on human samples at 1:250. Clin Neuropathol (2013) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human
In order to examine the relation of GATA3 and TGF beta in breast cancer cells, Abcam TWIST1 antibody (Abcam, ab50887) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3c
In order to evaluate the impact of claudin expression in grade I-III ependymomas, Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3c). Histol Histopathol (2013) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam TWIST1 antibody (Abcam, ab50887) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:500; fig 3h
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples at 1:500 (fig 3h). Commun Biol (2021) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 3d
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz Biotechnology, sc-81417) was used in western blot on human samples (fig 3d). Aging (Albany NY) (2020) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:200; loading ...; fig s2a
Santa Cruz Biotechnology TWIST1 antibody (Santa, sc-81417) was used in western blot on human samples at 1:200 (fig s2a). Sci Adv (2019) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2a
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, Twist2C1a) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2a). J Clin Invest (2019) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology TWIST1 antibody (Santa, sc-81417) was used in western blot on human samples (fig 5a). J Pathol (2019) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; mouse; 1:100; loading ...; fig 2b
Santa Cruz Biotechnology TWIST1 antibody (Santa, TWIST2C1a) was used in western blot on mouse samples at 1:100 (fig 2b). J Clin Invest (2018) ncbi
mouse monoclonal (Twist2C1a)
  • other; human; loading ...; fig 4c
Santa Cruz Biotechnology TWIST1 antibody (SantaCruz, sc-81417) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:50; fig s6i
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples at 1:50 (fig s6i). Nat Commun (2017) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples (fig 2b). BMC Cancer (2017) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:200; loading ...; fig 2d
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples at 1:200 (fig 2d). Cancer Sci (2017) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:500; loading ...; fig 1a
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples at 1:500 (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; fig 5b
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples (fig 5b). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • immunocytochemistry; human; 1:500; loading ...; fig 6c
  • western blot; human; 1:500; loading ...; fig 5a
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in immunocytochemistry on human samples at 1:500 (fig 6c) and in western blot on human samples at 1:500 (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • chromatin immunoprecipitation; human; loading ...; fig 2b
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in chromatin immunoprecipitation on human samples (fig 2b). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; fig 6a
In order to investigate the role of growth hormone in colon cancer, Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples (fig 6a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:100; loading ...; fig 5c
Santa Cruz Biotechnology TWIST1 antibody (SantaCruz, sc-81417) was used in western blot on human samples at 1:100 (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; 1:100; fig 1
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (Twist2C1a)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1c
Santa Cruz Biotechnology TWIST1 antibody (SantaCruz, sc81417) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1c). Dev Dyn (2016) ncbi
  • western blot; human; 1:200; fig 5
Santa Cruz Biotechnology TWIST1 antibody (santa Cruz, sc134136) was used in western blot on human samples at 1:200 (fig 5). Mol Med Rep (2016) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 1c
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology TWIST1 antibody (Santa Cruz, sc-81417) was used in western blot on human samples (fig 1c) and in western blot on mouse samples (fig 1b). Neoplasia (2015) ncbi
mouse monoclonal (Twist2C1a)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology TWIST1 antibody (SantaCruz, sc-81417) was used in western blot on human samples (fig 3c). Mol Med Rep (2015) ncbi
Novus Biologicals
mouse monoclonal (10E4E6)
  • immunohistochemistry; mouse; loading ...; fig s3b
Novus Biologicals TWIST1 antibody (Novus, NBP2?C37364) was used in immunohistochemistry on mouse samples (fig s3b). Cell Rep (2021) ncbi
R&D Systems
domestic sheep polyclonal
  • immunocytochemistry; human; loading ...; fig s1b
  • western blot; human; loading ...; fig s1b
R&D Systems TWIST1 antibody (R&D Systems, AF62301) was used in immunocytochemistry on human samples (fig s1b) and in western blot on human samples (fig s1b). Cell Death Differ (2019) ncbi
domestic sheep polyclonal
R&D Systems TWIST1 antibody (R&D Systems, AF6230) was used . Clin Cancer Res (2015) ncbi
Abnova
mouse monoclonal (2F8)
  • immunohistochemistry; human; 1:500; fig 2
Abnova TWIST1 antibody (Abnova, H00007291-M03) was used in immunohistochemistry on human samples at 1:500 (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (2F8)
  • immunocytochemistry; human; 1:500; fig 2
Abnova TWIST1 antibody (Abnova, H00007291-M03) was used in immunocytochemistry on human samples at 1:500 (fig 2). Int J Oncol (2015) ncbi
CovalAb
mouse monoclonal
  • western blot; human
CovalAb TWIST1 antibody (Covalab, mab0089-P) was used in western blot on human samples . Cancer Lett (2015) ncbi
Active Motif
mouse monoclonal
  • western blot; human
In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, Active Motif TWIST1 antibody (Active Motif, 61097) was used in western blot on human samples . Oncogene (2013) ncbi
Articles Reviewed
  1. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  2. Fan J, Li S, Wang D. MicroRNA-149 suppresses osteogenic differentiation of mesenchymal stem cells via inhibition of AKT1-dependent Twist1 phosphorylation. Cell Death Discov. 2022;8:2 pubmed publisher
  3. Ren J, Xu Y, Lu X, Wang L, Ide S, Hall G, et al. Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration. JCI Insight. 2021;6: pubmed publisher
  4. Wojnarowicz P, Escolano M, Huang Y, Desai B, Chin Y, Shah R, et al. Anti-tumor effects of an ID antagonist with no observed acquired resistance. NPJ Breast Cancer. 2021;7:58 pubmed publisher
  5. Harn H, Wang S, Lai Y, Van Handel B, Liang Y, Tsai S, et al. Symmetry breaking of tissue mechanics in wound induced hair follicle regeneration of laboratory and spiny mice. Nat Commun. 2021;12:2595 pubmed publisher
  6. Carstens J, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews K, et al. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep. 2021;35:108990 pubmed publisher
  7. Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
  8. Varela Eirin M, Carpintero Fernández P, Sánchez Temprano A, Varela Vazquez A, Paíno C, Casado Diaz A, et al. Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging (Albany NY). 2020;12:15882-15905 pubmed publisher
  9. Choi I, Lim H, Cho H, Oh Y, Chou B, Bai H, et al. Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors. elife. 2020;9: pubmed publisher
  10. Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
  11. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  12. Sonego M, Pellarin I, Costa A, Vinciguerra G, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv. 2019;5:eaav3235 pubmed publisher
  13. Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129-1151 pubmed publisher
  14. Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B, et al. F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function. J Pathol. 2019;248:266-279 pubmed publisher
  15. Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya M, Wang X, et al. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. J Clin Invest. 2018;128:4924-4937 pubmed publisher
  16. Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, et al. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 2019;26:306-320 pubmed publisher
  17. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  18. Liu L, Wu B, Cai H, Li D, Ma Y, Zhu X, et al. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/?-catenin signaling. Exp Cell Res. 2018;362:532-540 pubmed publisher
  19. Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Nat Commun. 2017;8:2207 pubmed publisher
  20. Saxon J, Baer D, Barton J, Hawkins T, Wu B, Trusk T, et al. BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling. Dev Biol. 2017;430:113-128 pubmed publisher
  21. Roberts C, Shahin S, Loeza J, Dellinger T, Williams J, Glackin C. Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target. BMC Cancer. 2017;17:184 pubmed publisher
  22. Li J, Liu Y, Yin Y. ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines. Onco Targets Ther. 2017;10:691-701 pubmed publisher
  23. Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, et al. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma. Cancer Sci. 2017;108:528-535 pubmed publisher
  24. Roberts C, Tran M, Pitruzzello M, Wen W, Loeza J, Dellinger T, et al. TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling. Sci Rep. 2016;6:37652 pubmed publisher
  25. Koch K, Hartmann R, Schröter F, Suwala A, Maciaczyk D, Krüger A, et al. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells. Oncotarget. 2016;7:73414-73431 pubmed publisher
  26. Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7:71400-71416 pubmed publisher
  27. Orlandella F, Di Maro G, Ugolini C, Basolo F, Salvatore G. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Oncotarget. 2016;7:70575-70588 pubmed publisher
  28. Kim M, Jeong J, Seo J, Kim H, Kim S, Jin W. Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Sci Rep. 2016;6:33899 pubmed publisher
  29. Oh B, Kim S, Lee Y, Hong H, Kim T, Kim S, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7:57066-57076 pubmed publisher
  30. Li C, Li Q, Cai Y, He Y, Lan X, Wang W, et al. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis. Cancer Gene Ther. 2016;23:295-302 pubmed publisher
  31. Wei C, Cheng J, Zhou B, Zhu L, Khan M, He T, et al. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein. Sci Rep. 2016;6:29822 pubmed publisher
  32. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  33. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  34. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
  35. Wu S, Rupaimoole R, Shen F, Pradeep S, Pecot C, Ivan C, et al. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nat Commun. 2016;7:11169 pubmed publisher
  36. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed publisher
  37. Sun X, Cui M, Zhang A, Tong L, Wang K, Li K, et al. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist. J Exp Clin Cancer Res. 2016;35:10 pubmed publisher
  38. Sakamoto A, Akiyama Y, Shimada S, Zhu W, Yuasa Y, Tanaka S. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells. PLoS ONE. 2015;10:e0145630 pubmed publisher
  39. Goodnough L, Dinuoscio G, ATIT R. Twist1 contributes to cranial bone initiation and dermal condensation by maintaining Wnt signaling responsiveness. Dev Dyn. 2016;245:144-56 pubmed publisher
  40. Zeng J, Quan J, Xia X. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells. Mol Med Rep. 2016;13:174-80 pubmed publisher
  41. Schirosi L, De Summa S, Tommasi S, Paradiso A, Sambiasi D, Popescu O, et al. Immunoprofile from tissue microarrays to stratify familial breast cancer patients. Oncotarget. 2015;6:27865-79 pubmed publisher
  42. Chen D, Dang B, Huang J, Chen M, Wu D, Xu M, et al. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer. Oncotarget. 2015;6:32701-12 pubmed publisher
  43. Mego M, Cierna Z, Janega P, Karaba M, Minarik G, Benca J, et al. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. BMC Cancer. 2015;15:533 pubmed publisher
  44. Zhao L, Liu S, Che X, Hou K, Ma Y, Li C, et al. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med. 2015;36:645-52 pubmed publisher
  45. Krossa S, Schmitt A, Hattermann K, Fritsch J, Scheidig A, Mehdorn H, et al. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1. Oncotarget. 2015;6:21029-45 pubmed
  46. Zheng S, Hedl M, Abraham C. Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators. J Immunol. 2015;195:217-26 pubmed publisher
  47. Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P, et al. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Lett. 2015;364:142-55 pubmed publisher
  48. Kubelt C, Hattermann K, Sebens S, Mehdorn H, Held Feindt J. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas. Int J Oncol. 2015;46:2515-25 pubmed publisher
  49. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  50. Gajula R, Chettiar S, Williams R, Nugent K, Kato Y, Wang H, et al. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells. Neoplasia. 2015;17:16-31 pubmed publisher
  51. Sun Z, Zhang C, Zou X, Jiang G, Xu Z, Li W, et al. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1. Mol Med Rep. 2015;11:3235-542 pubmed publisher
  52. Zhu D, Guo Q, Li Y, Cui B, Guo J, Liu J, et al. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. World J Gastroenterol. 2014;20:18306-15 pubmed publisher
  53. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed publisher
  54. Selmi A, de Saint Jean M, Jallas A, Garin E, Hogarty M, Bénard J, et al. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma. Cancer Lett. 2015;357:412-8 pubmed publisher
  55. Lee K, Yeo S, Sung C, Kim S. Twist1 is a key regulator of cancer-associated fibroblasts. Cancer Res. 2015;75:73-85 pubmed publisher
  56. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  57. Zhang X, Ma W, Cui J, Yao H, Zhou H, Ge Y, et al. Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia. Oncogene. 2015;34:3000-10 pubmed publisher
  58. Zhang P, Wei Y, Wang L, Debeb B, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864-75 pubmed publisher
  59. Loebel D, Hor A, Bildsoe H, Tam P. Timed deletion of Twist1 in the limb bud reveals age-specific impacts on autopod and zeugopod patterning. PLoS ONE. 2014;9:e98945 pubmed publisher
  60. Xu Y, Hu B, Qin L, Zhao L, Wang Q, Wang Q, et al. SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer. Int J Biol Sci. 2014;10:396-403 pubmed publisher
  61. Fukai J, Fujita K, Yamoto T, Sasaki T, Uematsu Y, Nakao N. Intracranial extension of adenoid cystic carcinoma: potential involvement of EphA2 expression and epithelial-mesenchymal transition in tumor metastasis: a case report. BMC Res Notes. 2014;7:131 pubmed publisher
  62. Li A, Morton J, Ma Y, Karim S, Zhou Y, Faller W, et al. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology. 2014;146:1386-96.e1-17 pubmed publisher
  63. Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, et al. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis. 2014;35:760-8 pubmed publisher
  64. Xu Y, Xu Y, Liao L, Zhou N, Theissen S, Liao X, et al. Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol. 2013;183:1281-1292 pubmed publisher
  65. Stewart C, Wang Y, Bonilla Claudio M, Martin J, Gonzalez G, Taketo M, et al. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development. Mol Endocrinol. 2013;27:1442-54 pubmed publisher
  66. Bai Y, Wang J, Morikawa Y, Bonilla Claudio M, Klysik E, Martin J. Bmp signaling represses Vegfa to promote outflow tract cushion development. Development. 2013;140:3395-402 pubmed publisher
  67. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H. Gliosarcoma with ependymal and PNET-like differentiation. Clin Neuropathol. 2013;32:508-14 pubmed publisher
  68. Chu I, Lai W, Aprelikova O, El Touny L, Kouros Mehr H, Green J. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. PLoS ONE. 2013;8:e61125 pubmed publisher
  69. Nordfors K, Haapasalo J, Sallinen P, Haapasalo H, Soini Y. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas. Histol Histopathol. 2013;28:1137-46 pubmed publisher
  70. Nagaishi M, Nobusawa S, Tanaka Y, Ikota H, Yokoo H, Nakazato Y. Slug, twist, and E-cadherin as immunohistochemical biomarkers in meningeal tumors. PLoS ONE. 2012;7:e46053 pubmed publisher
  71. Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher